Roxana Mehran learns more from Annapoorna Kini about her work to understand stable CAD plaque morphology, with the latest trial focused on the effects of PCSK9 inhibitors.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
